KALA BIO, Inc. (KALA) — Financial statements
Income statement, balance sheet, and cash flow for KALA BIO, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00↓100.0% | 4↓65.4% | 11 | |
| Cost of Revenue | 0.00↓100.0% | 0.26↓14.5% | 0.30↓88.2% | 3↓37.5% | 4 | |
| Gross Profit | 0.00↑100.0% | -0.26↑14.5% | -0.30↓122.7% | 1↓81.4% | 7 | |
| Operating Expenses | ||||||
| R&D Expenses | 19↓14.0% | 22↑17.5% | 19↑5.3% | 18↑53.3% | 12 | |
| General & Administrative Expenses | 24 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 24↑28.8% | 18↓9.5% | 20↓68.8% | 65↓38.1% | 105 | |
| Other Expenses | -3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 39↓2.5% | 40↑3.4% | 39↓53.0% | 83↓29.1% | 117 | |
| Total Costs & Expenses | 39↓3.1% | 40↑3.3% | 39↓54.1% | 85↓29.4% | 121 | |
| Operating Results | ||||||
| Operating Income | -39↑3.1% | -40↓3.3% | -39↑51.9% | -81↑25.7% | -109 | |
| Depreciation & Amortization | 0.32↑22.4% | 0.26↓14.5% | 0.30↓64.8% | 0.86↓62.1% | 2 | |
| EBITDA | -23↑41.8% | -40↓3.4% | -39↑51.7% | -80↑24.9% | -107 | |
| EBIT | -24↑41.4% | -40↓3.3% | -39↑51.9% | -81↑25.7% | -109 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↑42.7% | -4↓20.1% | -3↑53.0% | -7↑20.2% | -8 | |
| Interest Income | 1↓44.6% | 2↓24.2% | 3↑308.3% | 0.66↑538.5% | 0.10 | |
| Interest Expense | 3↓43.4% | 6↓0.5% | 6↓20.0% | 7↓13.3% | 8 | |
| Non-Operating Income | -15 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 12↑533.4% | 2↑163.1% | -3↓108.3% | 37↑210.1% | -33 | |
| Income Before Tax | -27↑29.9% | -39↑8.7% | -42↑5.9% | -45↑68.6% | -143 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -27↑29.9% | -39↑8.7% | -42↑5.9% | -45↑68.6% | -143 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -27↑29.9% | -39↑8.7% | -42↑5.9% | -45↑68.6% | -143 | |
| Bottom-Line Net Income | -27↑29.9% | -39↑8.7% | -42↑5.9% | -45↑68.6% | -143 | |
| EPS (Basic) | -3.31↑52.6% | -6.98↑59.8% | -17.35↑41.1% | -29.48↑73.0% | -109.35 | |
| EPS (Diluted) | -3.31↑52.6% | -6.98↑59.8% | -17.35↑41.1% | -29.48↑73.0% | -109.35 | |
| Weighted Average Shares | 8↑47.6% | 6↑127.0% | 2↑59.9% | 2↑16.6% | 1 | |
| Weighted Average Diluted Shares | 8↑47.6% | 6↑127.0% | 2↑59.9% | 2↑16.6% | 1 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.